Type 2 diabetes mellitus
Conditions
Interventions
Control group:The patient will undergo the current routine perioperative blood glucose management. This includes: standard bowel preparation instructions, blood glucose monitoring as directed by the d
Trial group:Based on routine care, the "SOP for Blood Glucose Management during the Perioperative Period of Non-Painful Colorectal ESD in Type 2 Diabetic Patients" constructed by this study was implem
preventive glucose supplementation at multiple time points (administer 20 ml of 50% glucose injection orally when the blood glucose monitoring value is 3.9–5.6 mmol/L, and recheck 15 minutes later
the target blood glucose should be 5.6–10.0 mmol/L
for 2 hours before the operation, glucose was supplemented through intravenous infusion)
acupoint massage and walking activity guidance
targeted assessment and counseling for hypoglycemia fear.
Sponsors
Peking University First Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Diagnosed with type 2 diabetes according to the "Standards of Medical Care in Diabetes" published by the American Diabetes Association (ADA) in 2025; 2. Age >=18 years; 3. Patients undergoing elective painless endoscopic submucosal dissection (ESD) for colorectal lesions; 4. Capable of effective communication and comprehension, mentally alert, mentally stable, able to understand questionnaire content and answer questions, capable of understanding the study details, willing to participate voluntarily, and able to sign a written informed consent form; 5. Able to follow the standard bowel preparation protocol.
Exclusion criteria
Exclusion criteria: 1. Patients with coronary heart disease, old myocardial infarction, renal insufficiency, shock, ascites; 2. Patients with gastrointestinal obstruction or suspected obstruction, intestinal perforation, gastric retention, gastrointestinal bleeding, toxic enteritis or toxic megacolon, intestinal diverticulum, severe ulcerative colitis; 3. Severe depression, schizophrenia; 4. Sensory or cognitive impairments, such as severe hearing impairment, dementia, inability to cooperate in completing the questionnaire or intervention measures; 5. Pregnant or lactating women; 6. Those known to be allergic to the components of the study drug; 7. Those planning to use non-standard intestinal preparation methods; 8. Glycated hemoglobin > 8%.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of perioperative hypoglycemia; | — |
Secondary
| Measure | Time frame |
|---|---|
| Standard deviation of blood sugar;Blood glucose coefficient of variation;Fear score of hypoglycemia;Intestinal cleansing rate;Incidence of perioperative hyperglycemia; | — |
Countries
China
Contacts
Public ContactDeng Hongce
Peking University First Hospital
Outcome results
None listed